Poor pregnancy outcome in women with type 2 diabetes.

PubWeight™: 1.71‹?› | Rank: Top 3%

🔗 View Article (PMID 15677787)

Published in Diabetes Care on February 01, 2005

Authors

Tine D Clausen1, Elisabeth Mathiesen, Pia Ekbom, Ellinor Hellmuth, Thomas Mandrup-Poulsen, Peter Damm

Author Affiliations

1: Department of Obstetrics, 4031, The Juliane Marie Centre Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9 DK-2100, Copenhagen Ø, Denmark. tine.clausen@rh.dk

Articles citing this

Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ (2006) 2.94

Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care (2008) 2.04

Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes Care (2010) 1.25

Adverse pregnancy outcomes in women with diabetes. Diabetol Metab Syndr (2012) 1.22

Integrating preconception care for women with diabetes into primary care: a qualitative study. Br J Gen Pract (2010) 1.13

Pregnancy outcome in type 2 diabetes mellitus: a retrospective analysis from the Netherlands. Rev Diabet Stud (2006) 1.03

Insulin pump for type 2 diabetes: use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes. Diabetes Care (2013) 0.98

Pregnancy outcomes of diabetic women: charting Oman's progress towards the goals of the Saint Vincent Declaration. Ann Saudi Med (2010) 0.97

An update on diabetic women obstetrical outcomes linked to preconception and pregnancy glycemic profile: a systematic literature review. ScientificWorldJournal (2013) 0.93

Increased Akt-mTOR signaling in lung epithelium is associated with respiratory distress syndrome in mice. Mol Cell Biol (2010) 0.90

Insulin and the lung: connecting asthma and metabolic syndrome. J Allergy (Cairo) (2013) 0.89

Birth defects in pregestational diabetes: Defect range, glycemic threshold and pathogenesis. World J Diabetes (2015) 0.88

Impact of restricted maternal weight gain on fetal growth and perinatal morbidity in obese women with type 2 diabetes. Diabetes Care (2012) 0.87

Risk factors for childhood overweight in offspring of type 1 diabetic women with adequate glycemic control during pregnancy: Nationwide follow-up study in the Netherlands. Diabetes Care (2009) 0.85

Fetal growth in relation to gestational weight gain in women with type 2 diabetes: an observational study. Diabet Med (2014) 0.82

High rate of placental infarcts in type 2 compared with type 1 diabetes. J Clin Endocrinol Metab (2012) 0.81

Risk of birth defects associated with maternal pregestational diabetes. Eur J Epidemiol (2014) 0.81

Diabetic embryopathy: a developmental perspective from fertilization to adulthood. Mol Syndromol (2013) 0.80

Similar adverse pregnancy outcome in native and nonnative dutch women with pregestational type 2 diabetes: a multicentre retrospective study. ISRN Obstet Gynecol (2013) 0.79

Prepregnancy care: a shared responsibility. Diabetes Care (2010) 0.78

Diabetes mellitus and pregnancy. Libyan J Med (2006) 0.78

Comparing type 1 and type 2 diabetes in pregnancy- similar conditions or is a separate approach required? BMC Pregnancy Childbirth (2015) 0.76

Cystic fibrosis-related diabetes in adults: where can we go from here? Rev Diabet Stud (2007) 0.76

Diabetic nephropathy and microalbuminuria in pregnant women with type 1 and type 2 diabetes: prevalence, antihypertensive strategy, and pregnancy outcome. Diabetes Care (2013) 0.76

Maternal and Neonatal Outcomes in Korean Women with Type 1 and Type 2 Diabetes. Diabetes Metab J (2015) 0.75

Peptidome analysis of human milk from women delivering macrosomic fetuses reveals multiple means of protection for infants. Oncotarget (2016) 0.75

Type 2 diabetes in pregnancy: importance of optimized care before, during and after pregnancy. Obstet Med (2008) 0.75

Four Pathways Involving Innate Immunity in the Pathogenesis of Preeclampsia. Front Cardiovasc Med (2015) 0.75

Severe diabetic nephropathy in type 1 diabetes and pregnancy--a case series. Rev Diabet Stud (2013) 0.75

Maternal Glucose and Fatty Acid Kinetics and Infant Birth Weight in Obese Women With Type 2 Diabetes. Diabetes (2016) 0.75

Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial. BMC Pregnancy Childbirth (2016) 0.75

Gestational and Pregestational Diabetes Mellitus in Omani Women: Comparison of obstetric and perinatal outcomes. Sultan Qaboos Univ Med J (2015) 0.75

Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy Childbirth (2012) 0.75

Poor glycemic control in younger women attending Malaysian public primary care clinics: findings from adults diabetes control and management registry. BMC Fam Pract (2013) 0.75

Articles by these authors

International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care (2010) 18.00

Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med (2007) 11.62

Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet (2011) 3.50

Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. Diabetes (2005) 3.18

High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care (2007) 3.13

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care (2008) 2.87

Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes (2005) 2.61

Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care (2009) 2.56

Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care (2004) 2.55

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet (2013) 2.45

Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J Clin Endocrinol Metab (2009) 2.15

Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med (Berl) (2003) 2.10

Role of IL-1beta in type 2 diabetes. Curr Opin Endocrinol Diabetes Obes (2010) 1.97

Albumin-to-creatinine ratio in random urine samples might replace 24-h urine collections in screening for micro- and macroalbuminuria in pregnant woman with type 1 diabetes. Diabetes Care (2006) 1.96

Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care (2007) 1.89

The prevalence of the metabolic syndrome in a danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab (2005) 1.80

Cytokines and beta-cell biology: from concept to clinical translation. Endocr Rev (2007) 1.72

Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets. Diabetes (2004) 1.72

Insulin resistance and impaired pancreatic β-cell function in adult offspring of women with diabetes in pregnancy. J Clin Endocrinol Metab (2013) 1.62

Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care (2004) 1.61

Proinflammatory cytokines activate the intrinsic apoptotic pathway in beta-cells. Diabetes (2009) 1.60

HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care (2004) 1.55

Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulation. Diabetes (2011) 1.52

Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care (2012) 1.46

Pregnancy outcome and prepregnancy body mass index in 2459 glucose-tolerant Danish women. Am J Obstet Gynecol (2003) 1.44

Total mortality by elevated transferrin saturation in patients with diabetes. Diabetes Care (2013) 1.43

Common type 2 diabetes risk gene variants associate with gestational diabetes. J Clin Endocrinol Metab (2008) 1.43

[Pregnancy following bariatric surgery requires special attention]. Ugeskr Laeger (2012) 1.43

Cytokine-induced proapoptotic gene expression in insulin-producing cells is related to rapid, sustained, and nonoscillatory nuclear factor-kappaB activation. Mol Endocrinol (2006) 1.39

Leisure time physical activity during pregnancy and impact on gestational diabetes mellitus, pre-eclampsia, preterm delivery and birth weight: a review. Acta Obstet Gynecol Scand (2007) 1.36

Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus. Mol Med (2011) 1.34

Gestational weight gain and pregnancy outcomes in 481 obese glucose-tolerant women. Diabetes Care (2005) 1.31

Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose? Acta Obstet Gynecol Scand (2008) 1.28

RNA modifications by oxidation: a novel disease mechanism? Free Radic Biol Med (2012) 1.26

IAPP boosts islet macrophage IL-1 in type 2 diabetes. Nat Immunol (2010) 1.24

Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol Endocrinol (2006) 1.22

Pregnancy-induced rise in serum C-peptide concentrations in women with type 1 diabetes. Diabetes Care (2009) 1.22

Hypoglycemia in type 1 diabetic pregnancy: role of preconception insulin aspart treatment in a randomized study. Diabetes Care (2009) 1.20

Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med (2011) 1.19

TiSH--a robust and sensitive global phosphoproteomics strategy employing a combination of TiO2, SIMAC, and HILIC. J Proteomics (2012) 1.19

The diagnosis of gestational diabetes mellitus: new paradigms or status quo? J Matern Fetal Neonatal Med (2012) 1.18

Audit on stillbirths in women with pregestational type 1 diabetes. Diabetes Care (2003) 1.16

From screening to postpartum follow-up - the determinants and barriers for gestational diabetes mellitus (GDM) services, a systematic review. BMC Pregnancy Childbirth (2014) 1.15

Screening for gestational diabetes mellitus by a model based on risk indicators: a prospective study. Am J Obstet Gynecol (2003) 1.13

Maternal and neonatal outcomes in pregnancies complicated by gestational diabetes. a nation-wide study. J Matern Fetal Neonatal Med (2015) 1.12

Human placenta secretes apolipoprotein B-100-containing lipoproteins. J Biol Chem (2004) 1.11

The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel. J Matern Fetal Neonatal Med (2013) 1.10

Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care (2012) 1.10

The Fas pathway is involved in pancreatic beta cell secretory function. Proc Natl Acad Sci U S A (2007) 1.08

The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care (2013) 1.08

Stillbirth in diabetic pregnancies. Best Pract Res Clin Obstet Gynaecol (2011) 1.07

Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol (2007) 1.07

The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet β cells in vivo and in vitro. Mol Med (2010) 1.05

Association between gestational weight gain according to body mass index and postpartum weight in a large cohort of Danish women. Matern Child Health J (2012) 1.03

Elevated transferrin saturation and risk of diabetes: three population-based studies. Diabetes Care (2011) 1.03

Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy? Diabetes Care (2008) 1.01

Placental triglyceride accumulation in maternal type 1 diabetes is associated with increased lipase gene expression. J Lipid Res (2006) 1.00

Long-term breast-feeding in women with type 1 diabetes. Diabetes Care (2006) 1.00

Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes. Diabetes Metab Res Rev (2011) 0.99

Further evidence that mutations in INS can be a rare cause of Maturity-Onset Diabetes of the Young (MODY). BMC Med Genet (2010) 0.99

Diabetes and suppressors of cytokine signaling proteins. Diabetes (2007) 0.99

The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus. Nat Clin Pract Endocrinol Metab (2008) 0.99

Sports and leisure time physical activity during pregnancy in nulliparous women. Matern Child Health J (2011) 0.98

High glucose suppresses human islet insulin biosynthesis by inducing miR-133a leading to decreased polypyrimidine tract binding protein-expression. PLoS One (2010) 0.97

Association of a functional 17beta-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in females. Hum Mol Genet (2003) 0.97

Leisure time physical activity is associated with a reduced risk of preterm delivery. Am J Obstet Gynecol (2008) 0.97

G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction. Endocrinology (2009) 0.96

Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes: results from a nationwide Danish study. Diabetes Care (2009) 0.96

Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care (2009) 0.95

Serum adipokines as biomarkers of beta-cell function in patients with type 1 diabetes: positive association with leptin and resistin and negative association with adiponectin. Diabetes Metab Res Rev (2013) 0.95

Divalent metal transporter 1 regulates iron-mediated ROS and pancreatic β cell fate in response to cytokines. Cell Metab (2012) 0.95

A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes. J Matern Fetal Neonatal Med (2013) 0.91

Inhibition of nuclear factor-kappaB or Bax prevents endoplasmic reticulum stress- but not nitric oxide-mediated apoptosis in INS-1E cells. Endocrinology (2009) 0.91

Endothelial and lipoprotein lipases in human and mouse placenta. J Lipid Res (2005) 0.90

Insulin dose during glucocorticoid treatment for fetal lung maturation in diabetic pregnancy: test of an algorithm [correction of analgoritm]. Acta Obstet Gynecol Scand (2002) 0.89

Calcium has a permissive role in interleukin-1beta-induced c-jun N-terminal kinase activation in insulin-secreting cells. Endocrinology (2005) 0.89

Managing type 1 diabetes mellitus in pregnancy--from planning to breastfeeding. Nat Rev Endocrinol (2012) 0.89

Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and β-cell protection. Proc Natl Acad Sci U S A (2014) 0.88

Impact of restricted maternal weight gain on fetal growth and perinatal morbidity in obese women with type 2 diabetes. Diabetes Care (2012) 0.87

Pregnancy in women with type 1 diabetes: have the goals of St. Vincent declaration been met concerning foetal and neonatal complications? J Matern Fetal Neonatal Med (2013) 0.86

Effect of smoking cessation on gestational and postpartum weight gain and neonatal birth weight. Obstet Gynecol (2013) 0.86

DALI: Vitamin D and lifestyle intervention for gestational diabetes mellitus (GDM) prevention: an European multicentre, randomised trial - study protocol. BMC Pregnancy Childbirth (2013) 0.86

Increased plasma pro-B-type natriuretic peptide in infants of women with type 1 diabetes. Clin Chem (2005) 0.86

Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: comparison of glycaemic control and pregnancy outcome. J Matern Fetal Neonatal Med (2012) 0.84

Apolipoprotein CIII reduces proinflammatory cytokine-induced apoptosis in rat pancreatic islets via the Akt prosurvival pathway. Endocrinology (2011) 0.84

Increase in maternal placental growth hormone during pregnancy and disappearance during parturition in normal and growth hormone-deficient pregnancies. Am J Obstet Gynecol (2003) 0.84

Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding. Rheumatology (Oxford) (2010) 0.84

Anti-cytokine therapies in T1D: Concepts and strategies. Clin Immunol (2013) 0.84

Increased LDL cholesterol and CRP in infants of mothers with type 1 diabetes. Diabetes Metab Res Rev (2008) 0.84

Pregnancy management of women with pregestational diabetes. Endocrinol Metab Clin North Am (2011) 0.84

Pregnancy-induced increase in circulating IGF-I is associated with progression of diabetic retinopathy in women with type 1 diabetes. Growth Horm IGF Res (2011) 0.83

Type 1 database mellitus: an inflammatory disease of the islet. Adv Exp Med Biol (2004) 0.83

Women born preterm or with inappropriate weight for gestational age are at risk of subsequent gestational diabetes and pre-eclampsia. PLoS One (2012) 0.83